Company Centrexion Therapeutics Corporation
Equities
CNTX
US15643W1009
Biotechnology & Medical Research
Business Summary
Number of employees: 24
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 76 | 13-01-31 | |
Jeffrey Kindler
FOU | Founder | 68 | 13-01-31 |
Chief Tech/Sci/R&D Officer | - | 15-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Swedish
BRD | Director/Board Member | 72 | 18-06-25 |
Sol Barer
FOU | Founder | 76 | 13-01-31 |
Jeffrey Kindler
FOU | Founder | 68 | 13-01-31 |
Peter Wirth
BRD | Director/Board Member | 73 | - |
Director/Board Member | 83 | 13-01-31 | |
Daniel Mendelson
BRD | Director/Board Member | 60 | 18-08-14 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 18-12-31 |
Founder | 76 | 13-01-31 | |
Sara Nayeem
BRD | Director/Board Member | 75 | 17-12-31 |
Shawn Tomasello
BRD | Director/Board Member | 65 | 17-06-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,669,866 | 0 | 0 | - |
Company contact information
Centrexion Therapeutics Corp.
200 State Street 6th floor
02109, Boston
+617-837-6911
http://www.centrexion.com![address Centrexion Therapeutics Corporation(CNTX)](https://cdn.zonebourse.com/static/address/47134020.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.71% | 44.63B | |
+42.66% | 40.46B | |
-7.92% | 38.07B | |
+33.09% | 32.27B | |
-7.10% | 27.3B | |
+14.46% | 26.53B | |
+46.73% | 14.06B | |
+34.07% | 12.54B | |
-7.61% | 11.28B |